Multiparametric Imaging for Analysis of MVNT (Multinodular and Vacuolating Neuronal Tumor)
NCT ID: NCT04103190
Last Updated: 2026-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
71 participants
OBSERVATIONAL
2019-12-10
2025-07-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Resolution Imaging for Analysis of MVNT
NCT04285125
Diffusion-weighted MRI to Predict Treatment Response in Stereotactic Radiotherapy of Central Nervous System (CNS) Metastases
NCT04700748
Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium
NCT04113395
MRI and Orbital Tumours (MEDORT)
NCT02401906
Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy
NCT04451265
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However, in order to avoid an invasive surgical procedure to remove the lesion, a certain diagnosis of its benignity is essential. The contribution of advanced techniques in MRI, such as spectroscopy in the characterization of these lesions, has not yet been studied today
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cerebral MRI
Patients who agree to participate in the study will perform a 3T multi-parametric MRI with advanced spectroscopic imaging techniques and standard protocol.
A neurological consultation will take place during the inclusion visit as well as a questionnaire and a control MRI at 1 year and 2 years +/- 1 month.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suspicion of MVNT on an MRI: it is considered that it will be necessary at least the 2 major criteria associated with at least 1 minor criterion to enter the definition of suspicion of MVNT:
Major criteria:
* Multinodular aspect in cluster
* High FLAIR hypersignal / T2
Minor criteria:
* Absence of mass effect
* Hyposignal T1
* Center of the lesion in hypsignal FLAIR or T1 hypersignal
* Affiliate or beneficiary of a Social Security scheme
* Having received informed information about the study and consenting to participate in the study
Exclusion Criteria
* Pregnant or lactating woman
* Contraindication to MRI
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Ophtalmologique Adolphe de Rothschild
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupe Hospitalier Pellegrin
Bordeaux, Bordeaux, France
Fondation Adolphe de Rothschild
Paris, PARIS, France
CHU Rennes
Rennes, Rennes, France
CHU de Rouen
Rouen, Rouen, France
Hôpital Pierre Paul Riquet, CHU Purpan
Toulouse, Toulouse, France
Centre Hospitalier Lyon Sud
Pierre-Bénite, , France
Hôpital Laennec
Saint-Herblain, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ALR_2019_4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.